Thomas Roulet, Associate Professor in Organisation Theory and Deputy Director of the MBA programme at Cambridge Judge Business School, is quoted in this article mentioning AstraZeneca’s anti-Covid19 vaccine.
“This vaccine showed this country’s ability to create ecosystems that combine an innovative company, great research universities, the public health system, a teaching hospital, and a state willing to facilitate the process,” says Thomas.
Read the full article [lepoint.fr]
Comments